1. Healthcare, Regulatory and Reimbursement Landscape - Israel
Report Details:
Published:December 2012
No. of Pages: 145
Price: Single User License – US$1995
Healthcare, Regulatory and Reimbursement Landscape - Israel
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatory
and Reimbursement Landscape - Israel”. An essential source of information and analysis on the
Israeli healthcare, regulatory and reimbursement landscape, it identifies the key trends in the
healthcare market and provides insights into the demographic, regulatory, and reimbursement
landscape and healthcare infrastructure. Most importantly, the report provides valuable insights
into the trends and segmentation of the pharmaceutical and medical device markets. It is built
using data and information sourced from proprietary databases, secondary research and in-house
analysis by GlobalData’s team of industry experts.
In 2011, Israel’s population was 7.8 million, largely due to a positive balance between the birth rate
and mortality rate. The mortality rate is declining due to improvements to healthcare infrastructure
and medical and diagnostic services. The pharmaceutical market was estimated to be worth $1.78
billion in 2010 and is expected to reach $2.3 billion by 2020 at a projected Compound Annual
Growth Rate (CAGR) of 2.3%. The medical device market was worth approximately $1.2 billion in
2011 and is expected to reach $1.9 billion by 2020 at a CAGR of 4.8%.
These positive trends in Israel’s healthcare market can primarily be attributed to -
- Growing awareness of health and well-being in society
- Competitive generic market
- Increasing availability of medicines
Scope
The report provides information on Israel’s healthcare, regulatory and reimbursement landscape,
including -
- Overview of the pharmaceutical and medical device markets, including size, segmentation, and
key drivers and barriers

2. - Profiles and SWOT analyses of the major players in the pharmaceutical and medical device
markets. The key players covered for the pharmaceutical market are Teva, Taro, Dexcel and
Rekah, and the key players covered for the medical device market are Medtronic, Boston
Scientific Corporation, Siemens Healthcare, B. Braun Melsungen and F. Hoffmann-La Roche.
- Insightful review of the reimbursement and regulatory landscape, with details of the
reimbursement process, regulatory agencies and market authorization processes for new drug
and medical devices
- Detailed analysis of Israel’s political and economic environment, including economic indicators,
demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
The report will enhance your decision-making capability and allow you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare
market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies,
pharmaceutical and medical devices market segments and companies likely to impact the
healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape
and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments
that present the most opportunities for consolidation, investment and strategic partnerships
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market
Get your copy of this report @
http://www.reportsnreports.com/reports/209357-healthcare-regulatory-and-reimbursement-landscape-israel.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 9
2.1 Report Guidance 9
3 Overview of Pharmaceutical and Medical Device Markets 10
3.1 Pharmaceutical Market 10
3.1.1 Overview of Pharmaceutical Market 10
3.1.2 Market Segment 13
3.1.3 Major Disease Areas 14
3.1.4 Major Players 15
3.2 Medical Device Market 30
3.2.1 Market Overview 30

3. 3.2.2 Overview of the Top Five Segments 32
3.2.3 Major Players 43
3.3 Market Drivers and Barriers 61
3.3.1 Drivers 61
3.3.2 Barriers 62
4 Market Access 63
4.1 Reimbursement and Payer Landscape 63
4.1.1 Reimbursement Process 63
4.1.2 Overview of Insurance Providers 65
4.1.3 Drug Price Trend 68
4.1.4 Pricing Policies 69
4.2 Regulatory Landscape 70
4.2.1 Overview of Regulatory Agencies 70
4.2.2 New Drug Approval Process 72
4.2.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing 72
4.2.4 Licensing Process for Pharmaceutical Exports and Imports 73
4.2.5 Intellectual Property Rights 74
4.2.6 Clinical Trial Regulations 75
4.2.7 Pharmaceutical and Medical Devices Advertising Regulations 76
4.2.8 Labeling and Packaging Regulations 77
5 Country Analysis 78
5.1 Political Environment 78
5.1.1 Political Structure 78
5.1.2 Analysis of Current Political Environment 79
5.1.3 Healthcare Policy Initiatives 80
5.2 Economic Landscape 81
5.3 Economic Indicators 82
5.3.1 Gross Domestic Product 82
5.3.2 Gross National Income 86
5.3.3 Inflation 87
5.3.4 Currency Exchange Rate 90
5.3.5 Foreign Direct Investment 91
5.3.6 Foreign Exchange Reserves 92
5.3.7 Trade Balance 93
5.3.8 Government Structural Balance 95
5.3.9 Government Net Debt 96
5.3.10 Major Industries 98
5.4 Demography 99
5.4.1 Population 99
5.4.2 Education and Literacy 114
5.4.3 Employment 116
5.4.4 Disease Burden 117

4. 5.4.5 Healthcare Facilities 119
5.4.6 Healthcare Parameters 123
5.4.7 Healthcare Personnel 124
5.4.8 Environmental Health 128
5.5 Healthcare Expenditure 131
5.5.1 Major Components of Healthcare Spending 132
5.5.2 Share of Public and Private Sector in Healthcare 133
5.5.3 Healthcare Expenditure by Financing Agent 134
5.5.4 Spending in Science and Technology R&D 135
5.6 Trade Associations 136
5.6.1 Pharmaceutical Association of Israel 136
5.6.2 Pharma Israel 136
5.7 Trade Fairs 137
6 Opportunities and Challenges 138
6.1 Opportunities 138
6.2 Challenges 139
7 Appendix 140
7.1 Abbreviations 140
7.2 Bibliography 141
7.3 Methodology 144
7.3.1 Coverage 144
7.3.2 Secondary Research 144
7.3.3 Forecasting 144
7.3.4 Primary Research 145
7.3.5 Expert Panel Validation 145
7.4 Contact Us 145
7.5 Disclaimer 145
1.1 List of Tables
Table 1: Pharmaceutical Market, Israel, Revenue ($bn), 2005-2010 11
Table 2: Pharmaceutical Market, Israel, Revenue ($bn), 2011-2020 12
Table 3: Major Biotechnology Companies and Products, 2011 13
Table 4: Major Products, Teva, Global, Revenue ($m), 2011 15
Table 5: Late-stage Pipeline, Teva, 2012 16
Table 6: Major Products, Taro, 2012 20
Table 7: Major Products, Dexcel Pharma, 2012 23
Table 8: Major Products, Rekah Pharmaceutical, 2012 27
Table 9: Medical Device Market, Israel, Revenue ($m), 2006-2011 30
Table 10: Medical Device Market, Israel, Revenue Forecast ($m), 2012-2020 31
Table 11: Medical Device Market, Israel, Segments, Revenue ($m), 2011 32
Table 12: Cardiovascular Devices Market, Israel, Revenue ($m), 2006-2011 33
Table 13: Sales Trends for Major Players*, Cardiovascular Devices, Israel, 2011 34

5. Table 14: Nephrology and Urology Devices, Israel, Revenue ($m), 2006-2011 35
Table 15: Sales Trends for Major Players*, Nephrology and Urology Devices, Israel, 2011 36
Table 16: In Vitro Diagnostics Market, Israel, Revenue ($m), 2006-2011 37
Table 17: Sales Trends for Major Players*, In Vitro Diagnostics Devices, Israel, 2010 38
Table 18: Ophthalmic Devices Market, Israel, Revenue ($m), 2006-2011 39
Table 19: Sales Trends for Major Players*, Ophthalmic Devices, Israel, 2010 40
Table 20: Orthopedic Devices Market, Israel, Revenue ($m), 2006-2011 41
Table 21: Sales Trends for Major Players*, Orthopedic Devices, Israel, 2011 42
Table 22: Major Medical Device Companies, Israel, Revenues ($m), 2010 43
Table 23: Major Products, Medtronic, Global, Revenue ($m), 2011 44
Table 24: Major Products, Boston, Global, Revenue ($m), 2010 49
Table 25: Major Products, Siemens Healthcare, Revenue ($m), 2012 51
Table 26: Late-stage Pipeline, Siemens Healthcare, 2012 52
Table 27: Major Product Division, B. Braun, Global, Revenue ($m), 2011 55
Table 28: Major Products, Roche, Global Revenues ($m), 2012 58
Table 29: Late-stage Pipeline, Roche, 2012 58
Table 30: Healthcare Spending, Israel, Patient Share (%), 2005-2010 66
Table 31: HMOs, Israel, Co-payment Cap for Chronically Ill Patients (NIS), 2012 66
Table 32: Drug Price Trends (%), Israel, 2006-2011 68
Table 33: HMOs, Israel, Co-payments for Chronically Ill Patients (NIS) (%), 2012 69
Table 34: GDP Per Capita ($’000), Israel, 2006-2011 82
Table 35: GDP Per Capita ($’000), Israel, Forecast, 2012-2020 83
Table 36: GDP, Annual Growth (%), Israel, 2006-2011 84
Table 37: GDP, Annual Growth (%), Israel, Forecast, 2012-2020 85
Table 38: GNI Per Capita ($’000), Israel, 2006-2011 86
Table 39: Average Consumer Price Index, Israel, 2006-2011 87
Table 40: Average Consumer Price Index, Israel, Forecast, 2012-2020 88
Table 41: Average Consumer Price, Israel, Annual Change (%), 2006-2011 89
Table 42: Currency Exchange Rate (NIS/$), Israel, 2006-2011 90
Table 43: Foreign Direct Investment ($bn), Israel, 2006-2011 91
Table 44: Foreign Exchange Reserves ($bn), Israel, 2006-2011 92
Table 45: Imports of Goods and Services ($bn), Israel, 2006-2011 93
Table 46: Exports of Goods and Services ($bn), Israel, 2006-2011 94
Table 47: General Government Structural Balance ($bn), Israel, 2005-2010 95
Table 48: General Government Net Debt ($bn), Israel, 2005-2010 96
Table 49: General Government Net Debt ($bn), Israel, Forecast, 2011-2020 97
Table 50: Major Industry Sectors, Net Domestic Product ($bn), Israel, 2010 98
Table 51: Population (‘000), Israel, 2006-2011 99
Table 52: Population (‘000), Israel, Forecast, 2012-2020 100
Table 53: Urban and Rural Population, Israel, Share (%), 2005-2010 101
Table 54: Age Groups, Israel, Population Distribution (%), 2005-2010 102
Table 55: Births (Per 1,000 Population), Israel, 2005-2010 103

6. Table 56: Births (Per 1,000 Population), Israel, Forecast, 2011-2020 104
Table 57: Mortality (Per 1,000 Population), Israel, 2006-2011 105
Table 58: Mortality (Per 1,000 Population), Israel, Forecast, 2012-2020 106
Table 59: Major Causes of Mortality (Per 100,000 Population), Israel, 2009 107
Table 60: Infant Mortality (Per 1,000 Live Births), Israel, 2006-2011 108
Table 61: Immunization Rate for MMR, DPT, Hib, HBV (%), Israel, 2005-2010 109
Table 62: Major Causes of Male Mortality (Per 10,0000 Population), Israel, 2009 110
Table 63: Major Causes of Female Mortality (Per 100,000 Population), Israel, 2009 111
Table 64: Gender Ratio (M/F), Israel, 2005-2010 112
Table 65: Life Expectancy at Birth (Years), Israel, 2005-2010 113
Table 66: National Expenditure, Israel, Education and Literacy (% of GDP), 2005-2010 114
Table 67: National Expenditure, Israel, Level of Education (%), 2007 115
Table 68: Unemployment Rate (%), Israel, 2005-2010 116
Table 69: Most Frequently Diagnosed Diseases (‘000), Israel, 2009 117
Table 70: Major Diseases, Israel, DALYs (Per 100,000 Population), 2004 118
Table 71: Total Number of Hospitals, Israel, 2005-2010 119
Table 72: Public and Private Hospitals, Israel, 2005-2010 120
Table 73: Types of Hospital, Israel, 2008-2010 121
Table 74: Long-term Care Hospitals, Israel, 2008-2010 122
Table 75: Hospital Beds (Per 1,000 Population), Israel, 2005-2010 123
Table 76: Doctors (Per 1,000 Population), Israel, 2005-2010 124
Table 77: Dentists (Per 1,000 Population), Israel, 2006-2011 125
Table 78: Nurses (Per 1,000 Population), Israel, 2006-2011 126
Table 79: Pharmacists (Per 1,000 Population), Israel, 2006-2011 127
Table 80: PM10 (µg/m3), Israel, 2005-2010 128
Table 81: CO2 Emissions (‘000 Tons), Israel, 2005-2010 129
Table 82: NOx, CO, SO2 Emissions (Tons), Israel, 2005-2010 130
Table 83: Healthcare Expenditure (% of GDP), Israel, 2005-2010 131
Table 84: Healthcare Expenditure, Israel, Types of Services (%), 2008 132
Table 85: Healthcare Expenditure, Israel, Public-Private Share (%), 2005-2010 133
Table 86: Healthcare Expenditure, Israel, Financing Agent (%), 2008 134
Table 87: R&D Expenditure, Israel, Science and Technology ($bn), 2005-2010 135
Table 88: Major Healthcare Trade Fairs, Israel, 2013-2014 137
1.2 List of Figures
Figure 1: Pharmaceutical Market, Israel, Revenue ($bn), 2005-2010 11
Figure 2: Pharmaceutical Market, Israel, Revenue, Forecast ($bn), 2011-2020 12
Figure 3: Medical Device Market, Israel, Revenue ($m), 2006-2011 30
Figure 4: Medical Device Market, Israel, Revenue Forecast ($m), 2012 --2020 31
Figure 5: Medical Device Market, Israel, Segments, Revenue ($m), 2011 32
Figure 6: Cardiovascular Devices Market, Israel, Revenue ($m), 2006-2011 33
Figure 7: Sales Trends for Major Players*, Cardiovascular Devices, Israel, 2006-2011 34

7. Figure 8: Nephrology and Urology Devices, Israel, Revenue ($m), 2006-2011 35
Figure 9: Sales Trends for Major Players*, Nephrology and Urology Devices, Israel, 2006-2011 36
Figure 10: In Vitro Diagnostics Market, Israel, Revenue ($m), 2006-2011 37
Figure 11: Sales Trends for Major Players*, In Vitro Diagnostics Devices, Israel, 2006-2010 38
Figure 12: Ophthalmic Devices Market, Israel, Revenue ($m), 2006-2011 39
Figure 13: Sales Trends for Major Players*, Ophthalmic Devices, Israel, 2006-2010 40
Figure 14: Orthopedic Devices Market, Israel, Revenue ($m), 2006-2011 41
Figure 15: Sales Trends for Major Players*, Orthopedic Devices, Israel, 2006-2011 42
Figure 16: Major Medical Device Companies, Israel, Revenues ($m), 2010 43
Figure 17: Drivers and Barriers, Healthcare Market, Israel, 2012 62
Figure 18: Overview of Healthcare System, Israel, 2012 64
Figure 19: Healthcare Spending, Israel, Patient Share (%), 2005-2010 66
Figure 20: Drug Price Trends (%), Israel, 2006-2011 68
Figure 21: Overview of Regulatory Bodies, Israel, 2012 71
Figure 22: GDP Per Capita ($’000), Israel, 2006-2011 82
Figure 23: GDP Per Capita ($’000), Israel, Forecast, 2012-2020 83
Figure 24: GDP, Annual Growth (%), Israel, 2006-2011 84
Figure 25: GDP, Annual Growth (%), Israel, Forecast, 2012-2020 85
Figure 26: GNI Per Capita ($’000), Israel, 2006-2011 86
Figure 27: Average Consumer Price Index, Israel, 2006-2011 87
Figure 28: Average Consumer Price Index, Israel, Forecast, 2012-2020 88
Figure 29: Average Consumer Price, Israel, Annual Change (%), 2006-2011 89
Figure 30: Currency Exchange Rate (ILS/$), Israel, 2006-2011 90
Figure 31: Foreign Direct Investment ($bn), Israel, 2006-2011 91
Figure 32: Foreign Exchange Reserves ($bn), Israel, 2006-2011 92
Figure 33: Imports of Goods and Services ($bn), Israel, 2006-2011 93
Figure 34: Exports of Goods and Services ($bn), Israel, 2006-2011 94
Figure 35: General Government Structural Balance ($bn), Israel, 2005-2010 95
Figure 36: General Government Net Debt ($bn), Israel, 2005-2010 96
Figure 37: General Government Net Debt ($bn), Israel, Forecast, 2011-2020 97
Figure 38: Major Industry Sectors, Net Domestic Product ($bn), Israel, 2010 98
Figure 39: Population (000’s), Israel, 2006-2011 99
Figure 40: Population (000’s), Israel, Forecast, 2012-2020 100
Figure 41: Urban and Rural Population, Israel, Share (%), 2005-2010 101
Figure 42: Age Groups, Israel, Population Distribution (%), 2005-2010 102
Figure 43: Births (Per 1,000 Population), Israel, 2005-2010 103
Figure 44: Births (Per 1,000 Population), Israel, Forecast, 2011-2020 104
Figure 45: Mortality (Per 1,000 Population), Israel, 2006-2011 105
Figure 46: Mortality (Per 1,000 Population), Israel, Forecast, 2012-2020 106
Figure 47: Major Causes of Mortality (Per 100,000 Population), Israel, 2009 107
Figure 48: Infant Mortality (Per 1,000 Live Births), Israel, 2006-2011 108
Figure 49: Immunization Rate for MMR, DPT, Hib, HBV (%), Israel, 2005-2010 109

8. Figure 50: Major Causes of Male Mortality (Per 100,000 Population), Israel, 2009 110
Figure 51: Major Causes of Female Mortality (Per 10,0000 Population), Israel, 2009 111
Figure 52: Gender Ratio (M/F), Israel, 2005-2010 112
Figure 53: Life Expectancy at Birth (Years), Israel, 2005-2010 113
Figure 54: National Expenditure, Israel, Education and Literacy (% of GDP), 2005-2010 114
Figure 55: National Expenditure, Israel, Level of Education (%), 2007 115
Figure 56: Unemployment Rate (%), Israel, 2005-2010 116
Figure 57: Most Frequently Diagnosed Diseases (‘000), Israel, 2009 117
Figure 58: Major Diseases, Israel, DALYs (Per 100,000 Population), 2004 118
Figure 59: Total Number of Hospitals, Israel, 2005-2010 119
Figure 60: Public and Private Hospitals, Israel, 2005-2010 120
Figure 61: Types of Hospital, Israel, 2008-2010 121
Figure 62: Long-term Care Hospitals, Israel, 2008-2010 122
Figure 63: Hospital Beds (Per 1,000 Population), Israel, 2005-2010 123
Figure 64: Doctors (Per 1,000 Population), Israel, 2005-2010 124
Figure 65: Dentists (Per 1,000 Population), Israel, 2006-2011 125
Figure 66: Nurses (Per 1,000 Population), Israel, 2006-2011 126
Figure 67: Pharmacists (Per 1,000 Population), Israel, 2006-2011 127
Figure 68: PM10 (µg/m3), Israel, 2005-2010 128
Figure 69: CO2 Emissions (‘000 Tons), Israel, 2005-2010 129
Figure 70: NOx, CO, SOX Emissions (Tons), Israel, 2005-2010 130
Figure 71: Healthcare Expenditure (% of GDP), Israel, 2005-2010 131
Figure 72: Healthcare Expenditure, Israel, Types of Services (%), 2008 132
Figure 73: Healthcare Expenditure, Israel, Public-Private Share (%), 2005-2010 133
Figure 74: Healthcare Expenditure, Israel, Financing Agent (%), 2008 134
Figure 75: R&D Expenditure, Israel, Science and Technology ($bn), 2005-2010 135
Figure 76: Opportunities and Challenges, Healthcare Market, Israel, 2012 139
Contact: sales@reportsandreports.com for more information.